Latest News and Press Releases

CAMBRIDGE, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded...

Continued restaurant sales recovery with over 10% year over year increase in same store sales1 vs Q3 2020Subsequent to the quarter, completed acquisition of majority control of health and wellness...

The most extensive toolbox of proprietary genomic editors in the industry to enable development of curative, next-generation genetic medicines Co-founded by David Walt, Ph.D. and Feng Zhang, Ph.D. ...

NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- St. Joseph's Health and Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced a partnership to implement an advanced clinical care model designed to...

Sales of $679 million, a decrease of 8%EBITDA of $69 million, or a margin of 10.2%, including a $7 million write-down provision for inventoryNet income of $34 million, or $0.52 per shareRevised 2021...

CUPERTINO, Calif. and DAYTON, Ohio, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Celona, the leading innovator of 5G LAN solutions, and HarborLink Network, a pioneer in providing managed wireless services...

DURHAM, N.C., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...

DENVER, Nov. 09, 2021 (GLOBE NEWSWIRE) -- EDCare is pleased to announce the appointment of Riley Nickols, Ph.D., CEDS, to its Scientific Advisory Board. A highly experienced counseling and sports...

Since receiving FDA approval in 2001, Deflux® has enabled thousands of children to receive a highly effective, minimally invasive, same-day treatment for VUR. Deflux has revolutionized the treatment...

CMR global footprint grows with regulatory approval for Versius in Brazil Brazil will be the 11th country to introduce Versius, following Anvisa approval for use in adults by physicians trained in an...